Galderma (GALD): Successful Injection in Swiss & Global Indices
Galderma (GALD SW) is set to be a major addition to Global and Swiss Indices in August and September 2024 reviews after a $17bn IPO in March 2024.
Shift Now to Defensives; Snap-Back Rally Testing Resistance $ACWI $SPX; Neutral Outlook Intact
Shift Now to Defensives (Health Care, Telecommunications, Utilities, and Consumer Staples); Snap-Back Rally Testing Resistance $ACWI $SPX; Neutral...
No more insights